×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Provention Bio Inc. (PRVB) NASDAQ

$24.98 - (-)

Market Cap: -

As of 04/26/23 12:00 AM EDT. Market closed.

(PRVB)

Provention Bio Inc. (PRVB)
NASDAQ

$24.98
- (-)

Market Cap: -

As of 04/26/23 12:00 AM EDT. Market closed.

Add to Portfolio

Provention Bio, Inc. is a biopharmaceutical company focused on advancing the development of investigational therapies that may intercept and prevent debilitating and life-threatening immune-mediated disease. The Biologics License Application (BLA) for teplizumab, its lead investigational drug candidate, for the delay or prevention of clinical type 1 diabetes in at-risk individuals, has been filed ... read more

Provention Bio, Inc. is a biopharmaceutical company focused on advancing the development of investigational therapies that may intercept and prevent debilitating and life-threatening immune-mediated disease. The Biologics License Application (BLA) for teplizumab, its lead investigational drug candidate, for the delay or prevention of clinical type 1 diabetes in at-risk individuals, has been filed by the U.S. Food and Drug Administration (FDA). The Company's pipeline includes additional clinical-stage product candidates that have demonstrated in pre-clinical or clinical studies proof-of-mechanism and/or proof-of-concept in other autoimmune diseases, including celiac disease and lupus. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
CEO
Ashleigh Palmer
Full Time Employees
82
URL
Address
55 Broad Street, 2Nd Floor, New Jersey, Red Bank, 07701.
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
CEO
Ashleigh Palmer
Full Time Employees
82
Address
55 Broad Street, 2Nd Floor, New Jersey, Red Bank, 07701.
PRICE CHART FOR PROVENTION BIO INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$24.98
Days Range
$24.98 - $25
52 week range
- - -
Volume
9,124,151
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
94,780,874
Open
-
Previous Close
$24.98
Days Range
$24.98 - $25
52 week range
- - -
Volume
9,124,151
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
94,780,874
FINANCIAL STATEMENTS FOR PROVENTION BIO INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR PROVENTION BIO INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Sessa Capital (Master), L.P.10% OwnerApr 14, 2023 Sale$24.322,190,54953,274,15115,567,497Apr 18, 2023, 08:57 PM
Sessa Capital (Master), L.P.10% OwnerApr 14, 2023 Option Exercise$6.008,879,02353,274,13817,758,046Apr 18, 2023, 08:57 PM
Leon FranciscoChief Scientific OfficerFeb 13, 2023 Option Exercise$2.5025,98564,9631,598,985Feb 14, 2023, 07:19 PM
Leon FranciscoChief Scientific OfficerFeb 10, 2023 Option Exercise$2.5050,000125,0001,623,000Feb 14, 2023, 07:19 PM
Leon FranciscoChief Scientific OfficerFeb 13, 2023 Sale$10.0425,985260,9441,573,000Feb 14, 2023, 07:19 PM
Leon FranciscoChief Scientific OfficerFeb 10, 2023 Sale$10.1150,000505,6051,573,000Feb 14, 2023, 07:19 PM
Hoitt JasonChief Commercial OfficerFeb 10, 2023 Sale$10.004,50045,0050Feb 14, 2023, 07:16 PM
Palmer AshleighDirector and CEOFeb 13, 2023 Option Exercise$2.5025,83564,5882,595,885Feb 14, 2023, 07:13 PM
Palmer AshleighDirector and CEOFeb 10, 2023 Option Exercise$2.5050,000125,0002,620,050Feb 14, 2023, 07:13 PM
Palmer AshleighDirector and CEOFeb 13, 2023 Sale$10.0425,835259,4482,570,050Feb 14, 2023, 07:13 PM
Palmer AshleighDirector and CEOFeb 10, 2023 Sale$10.1150,000505,5552,570,050Feb 14, 2023, 07:13 PM
Palmer AshleighDirector and CEOJan 18, 2023 Option Exercise$2.5024,16560,4132,594,215Jan 20, 2023, 08:00 PM
Palmer AshleighDirector and CEOJan 18, 2023 Sale$10.2724,165248,0632,570,050Jan 20, 2023, 08:00 PM
Leon FranciscoChief Scientific OfficerJan 18, 2023 Option Exercise$2.5024,01560,0381,597,015Jan 20, 2023, 08:00 PM
Leon FranciscoChief Scientific OfficerJan 18, 2023 Sale$10.2724,015246,5841,573,000Jan 20, 2023, 08:00 PM
Sessa Capital (Master), L.P.10% OwnerJan 18, 2023 Sale$9.403,000,00028,199,99911,879,023Jan 20, 2023, 04:10 PM
Leon FranciscoChief Scientific OfficerDec 29, 2022 Option Exercise$2.50187,000467,5001,760,000Dec 30, 2022, 04:01 PM
Leon FranciscoChief Scientific OfficerDec 29, 2022 Sale$10.26187,0001,918,6011,573,000Dec 30, 2022, 04:01 PM
Leon FranciscoChief Scientific OfficerDec 27, 2022 Option Exercise$2.5010,67426,6851,583,674Dec 29, 2022, 04:01 PM
Leon FranciscoChief Scientific OfficerDec 27, 2022 Sale$10.0010,674106,7401,573,000Dec 29, 2022, 04:01 PM
Leon FranciscoChief Scientific OfficerDec 23, 2022 Option Exercise$2.503759381,573,375Dec 27, 2022, 05:51 PM
Leon FranciscoChief Scientific OfficerDec 22, 2022 Option Exercise$2.501,5683,9201,574,568Dec 27, 2022, 05:51 PM
Leon FranciscoChief Scientific OfficerDec 23, 2022 Sale$10.003753,7501,573,000Dec 27, 2022, 05:51 PM
Leon FranciscoChief Scientific OfficerDec 22, 2022 Sale$10.001,56815,6811,573,000Dec 27, 2022, 05:51 PM
Ramos EleanorChief Medical OfficerDec 03, 2021 Buy$6.495,20133,76570,000Dec 06, 2021, 09:28 PM
Palmer AshleighDirector and CEONov 30, 2021 Buy$6.663,75024,9902,570,050Dec 01, 2021, 09:21 PM
Leon FranciscoChief Scientific OfficerNov 24, 2021 Buy$7.245,55040,1882,573,000Nov 29, 2021, 05:15 PM
Ramos EleanorChief Medical OfficerSep 02, 2020 Buy$12.062993,60664,799Sep 02, 2020, 07:43 PM
Drechsler Andrew TChief Financial OfficerSep 02, 2020 Buy$11.722,00023,44020,000Sep 02, 2020, 05:00 PM
Leon FranciscoChief Scientific OfficerAug 21, 2020 Buy$13.352,00026,7082,567,450Aug 21, 2020, 04:05 PM
Ramos EleanorChief Medical OfficerAug 20, 2020 Buy$13.232,50033,07564,500Aug 20, 2020, 06:52 PM
Palmer AshleighPresident and CEOAug 18, 2020 Buy$12.695006,3452,566,300Aug 18, 2020, 06:10 PM
Palmer AshleighPresident and CEOAug 17, 2020 Buy$12.832,80035,9242,565,800Aug 17, 2020, 07:20 PM
Drechsler Andrew TChief Financial OfficerAug 13, 2020 Buy$13.011,75022,76818,000Aug 13, 2020, 07:01 PM
Leon FranciscoChief Scientific OfficerJun 24, 2020 Buy$15.432,00030,8622,565,450Jun 24, 2020, 04:22 PM
Bluestone JeffreyDirectorApr 10, 2020 Option Exercise$2.3632,24676,10139,571Apr 14, 2020, 05:00 PM
Leon FranciscoChief Scientific OfficerMar 19, 2020 Buy$5.9210,00059,2002,563,450Mar 20, 2020, 06:15 AM
Hoitt JasonChief Commercial OfficerMar 19, 2020 Buy$5.434,50024,4354,500Mar 20, 2020, 06:15 AM
Ramos EleanorCMO & COODec 26, 2019 Buy$14.342,00028,68062,000Dec 26, 2019, 05:00 PM
Palmer AshleighPresident and CEODec 20, 2019 Buy$11.392,07523,6342,563,000Dec 23, 2019, 04:30 PM
Leon FranciscoChief Scientific OfficerDec 16, 2019 Buy$11.922,00023,8402,553,450Dec 16, 2019, 05:00 PM
Leon FranciscoChief Scientific OfficerSep 30, 2019 Buy$7.671,45011,1222,551,450Sep 30, 2019, 05:00 PM
DIGIANDOMENICO ANTHONYDirectorSep 30, 2019 Buy$6.8330,000204,900178,712Sep 30, 2019, 05:00 PM
DIGIANDOMENICO ANTHONYDirectorSep 26, 2019 Buy$8.445,00042,200148,712Sep 26, 2019, 06:08 PM
DIGIANDOMENICO ANTHONYDirectorSep 25, 2019 Buy$8.395,00041,950143,712Sep 25, 2019, 05:45 PM
Palmer AshleighPresident and CEOSep 24, 2019 Buy$8.383,00025,1402,560,925Sep 24, 2019, 07:04 PM
DIGIANDOMENICO ANTHONYDirectorAug 08, 2019 Buy$9.0910,00090,900138,712Aug 09, 2019, 06:01 AM
Leon FranciscoChief Scientific OfficerAug 08, 2019 Buy$9.092,50022,7252,550,000Aug 09, 2019, 06:01 AM
Palmer AshleighPresident and CEOAug 08, 2019 Buy$9.1510,60096,9902,557,925Aug 09, 2019, 06:01 AM
DIGIANDOMENICO ANTHONYDirectorJun 20, 2019 Buy$10.9610,000109,600128,712Jun 20, 2019, 05:37 PM
DIGIANDOMENICO ANTHONYDirectorJun 18, 2019 Buy$10.8810,000108,800118,712Jun 18, 2019, 09:00 PM
Palmer AshleighPresident and CEOJun 18, 2019 Buy$10.834,00043,3202,547,325Jun 18, 2019, 09:00 PM
Bluestone JeffreyDirectorJun 17, 2019 Sale$11.937,30087,0897,325Jun 17, 2019, 06:00 PM
DIGIANDOMENICO ANTHONYDirectorJun 17, 2019 Buy$12.1625,000304,000108,712Jun 17, 2019, 06:00 PM
Leon FranciscoChief Scientific OfficerDec 31, 2018 Buy$1.6410,00016,4002,547,500Jan 02, 2019, 06:00 PM
DIGIANDOMENICO ANTHONYDirectorDec 28, 2018 Buy$1.7610,00017,60083,712Dec 31, 2018, 06:00 PM
Palmer AshleighPresident and CEODec 31, 2018 Buy$1.588251,3042,543,325Dec 31, 2018, 06:00 PM
Palmer AshleighPresident and CEODec 28, 2018 Buy$1.735,0008,6502,542,500Dec 31, 2018, 06:00 PM
Pisano WayneDirectorDec 28, 2018 Buy$1.805,0009,0007,500Dec 31, 2018, 06:00 PM
DIGIANDOMENICO ANTHONYDirectorDec 27, 2018 Buy$1.9520,00039,00073,712Dec 28, 2018, 06:00 PM
DIGIANDOMENICO ANTHONYDirectorDec 24, 2018 Buy$1.9217,27033,15853,712Dec 27, 2018, 06:00 PM
CATLIN AVERY WDirectorDec 26, 2018 Buy$1.855,0009,25020,000Dec 27, 2018, 06:00 PM
CATLIN AVERY WDirectorDec 24, 2018 Buy$1.905,0009,50015,000Dec 27, 2018, 06:00 PM
DIGIANDOMENICO ANTHONYDirectorDec 21, 2018 Buy$1.852,0003,70036,442Dec 26, 2018, 06:00 PM
DIGIANDOMENICO ANTHONYDirectorDec 20, 2018 Buy$1.965,0009,80034,442Dec 21, 2018, 06:00 PM
DIGIANDOMENICO ANTHONYDirectorDec 03, 2018 Buy$2.454,44210,88329,442Dec 06, 2018, 06:00 PM
DIGIANDOMENICO ANTHONYDirectorNov 30, 2018 Buy$2.454,84911,88025,000Dec 03, 2018, 07:13 PM
DIGIANDOMENICO ANTHONYDirectorNov 29, 2018 Buy$2.4715137320,151Dec 03, 2018, 07:13 PM
DIGIANDOMENICO ANTHONYDirectorNov 27, 2018 Buy$2.4610,00024,60020,000Nov 28, 2018, 06:11 PM
DIGIANDOMENICO ANTHONYDirectorNov 26, 2018 Buy$2.6510,00026,50010,000Nov 27, 2018, 06:00 PM
Drechsler Andrew TChief Financial OfficerNov 13, 2018 Option Exercise$2.5010,00025,00016,250Nov 14, 2018, 08:00 PM
CATLIN AVERY WDirectorNov 09, 2018 Buy$3.1510,00031,50010,000Nov 13, 2018, 07:00 AM
APPEL PETER A10% OwnerJul 19, 2018 Buy$4.00750,0003,000,0001,950,000Jul 26, 2018, 04:50 PM
Pisano WayneDirectorJul 19, 2018 Buy$4.002,50010,0002,500Jul 19, 2018, 05:59 PM
Palmer AshleighPresident and CEOJul 19, 2018 Buy$4.0037,500150,0002,537,500Jul 19, 2018, 05:58 PM
Leon FranciscoChief Scientific OfficerJul 19, 2018 Buy$4.0037,500150,0002,537,500Jul 19, 2018, 05:58 PM
Drechsler Andrew TChief Financial OfficerJul 19, 2018 Buy$4.006,25025,0006,250Jul 19, 2018, 05:56 PM
Ramos EleanorChief Medical Officer & COOJul 19, 2018 Buy$4.0060,000240,00060,000Jul 19, 2018, 05:55 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Sessa Capital (Master), L.P.10% Owner04/14/202353,274,151
Sessa Capital (Master), L.P.10% Owner04/14/202353,274,138
Leon FranciscoChief Scientific Officer02/13/202364,963
Leon FranciscoChief Scientific Officer02/10/2023125,000
Leon FranciscoChief Scientific Officer02/13/2023260,944
Leon FranciscoChief Scientific Officer02/10/2023505,605
Hoitt JasonChief Commercial Officer02/10/202345,005
Palmer AshleighDirector and CEO02/13/202364,588
Palmer AshleighDirector and CEO02/10/2023125,000
Palmer AshleighDirector and CEO02/13/2023259,448
Palmer AshleighDirector and CEO02/10/2023505,555
Palmer AshleighDirector and CEO01/18/202360,413
Palmer AshleighDirector and CEO01/18/2023248,063
Leon FranciscoChief Scientific Officer01/18/202360,038
Leon FranciscoChief Scientific Officer01/18/2023246,584
Sessa Capital (Master), L.P.10% Owner01/18/202328,199,999
Leon FranciscoChief Scientific Officer12/29/2022467,500
Leon FranciscoChief Scientific Officer12/29/20221,918,601
Leon FranciscoChief Scientific Officer12/27/202226,685
Leon FranciscoChief Scientific Officer12/27/2022106,740
Leon FranciscoChief Scientific Officer12/23/2022938
Leon FranciscoChief Scientific Officer12/22/20223,920
Leon FranciscoChief Scientific Officer12/23/20223,750
Leon FranciscoChief Scientific Officer12/22/202215,681
Ramos EleanorChief Medical Officer12/03/202133,765
Palmer AshleighDirector and CEO11/30/202124,990
Leon FranciscoChief Scientific Officer11/24/202140,188
Ramos EleanorChief Medical Officer09/02/20203,606
Drechsler Andrew TChief Financial Officer09/02/202023,440
Leon FranciscoChief Scientific Officer08/21/202026,708
Ramos EleanorChief Medical Officer08/20/202033,075
Palmer AshleighPresident and CEO08/18/20206,345
Palmer AshleighPresident and CEO08/17/202035,924
Drechsler Andrew TChief Financial Officer08/13/202022,768
Leon FranciscoChief Scientific Officer06/24/202030,862
Bluestone JeffreyDirector04/10/202076,101
Leon FranciscoChief Scientific Officer03/19/202059,200
Hoitt JasonChief Commercial Officer03/19/202024,435
Ramos EleanorCMO & COO12/26/201928,680
Palmer AshleighPresident and CEO12/20/201923,634
Leon FranciscoChief Scientific Officer12/16/201923,840
Leon FranciscoChief Scientific Officer09/30/201911,122
DIGIANDOMENICO ANTHONYDirector09/30/2019204,900
DIGIANDOMENICO ANTHONYDirector09/26/201942,200
DIGIANDOMENICO ANTHONYDirector09/25/201941,950
Palmer AshleighPresident and CEO09/24/201925,140
DIGIANDOMENICO ANTHONYDirector08/08/201990,900
Leon FranciscoChief Scientific Officer08/08/201922,725
Palmer AshleighPresident and CEO08/08/201996,990
DIGIANDOMENICO ANTHONYDirector06/20/2019109,600
DIGIANDOMENICO ANTHONYDirector06/18/2019108,800
Palmer AshleighPresident and CEO06/18/201943,320
Bluestone JeffreyDirector06/17/201987,089
DIGIANDOMENICO ANTHONYDirector06/17/2019304,000
Leon FranciscoChief Scientific Officer12/31/201816,400
DIGIANDOMENICO ANTHONYDirector12/28/201817,600
Palmer AshleighPresident and CEO12/31/20181,304
Palmer AshleighPresident and CEO12/28/20188,650
Pisano WayneDirector12/28/20189,000
DIGIANDOMENICO ANTHONYDirector12/27/201839,000
DIGIANDOMENICO ANTHONYDirector12/24/201833,158
CATLIN AVERY WDirector12/26/20189,250
CATLIN AVERY WDirector12/24/20189,500
DIGIANDOMENICO ANTHONYDirector12/21/20183,700
DIGIANDOMENICO ANTHONYDirector12/20/20189,800
DIGIANDOMENICO ANTHONYDirector12/03/201810,883
DIGIANDOMENICO ANTHONYDirector11/30/201811,880
DIGIANDOMENICO ANTHONYDirector11/29/2018373
DIGIANDOMENICO ANTHONYDirector11/27/201824,600
DIGIANDOMENICO ANTHONYDirector11/26/201826,500
Drechsler Andrew TChief Financial Officer11/13/201825,000
CATLIN AVERY WDirector11/09/201831,500
APPEL PETER A10% Owner07/19/20183,000,000
Pisano WayneDirector07/19/201810,000
Palmer AshleighPresident and CEO07/19/2018150,000
Leon FranciscoChief Scientific Officer07/19/2018150,000
Drechsler Andrew TChief Financial Officer07/19/201825,000
Ramos EleanorChief Medical Officer & COO07/19/2018240,000
Load More Insider Transactions
FUNDS WITH A POSITION IN PROVENTION BIO INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
ALPINE GLOBAL MANAGEMENT, LLC25,1500.24%ExitedEvent Driven
BUYBACK ANNOUNCEMENT(S) FOR PROVENTION BIO INC
LOADING...